“…The fast shift from behavioral to medical interventions has inherent barriers to implementation (Pinto, Berringer, Melendez, & Mmeje, ), and the surge of HIV‐prevention biomedical interventions has exacerbated already existing racial and gender disparities in HIV prevention and treatment—for instance, disproportionately low PrEP uptake among black MSM (Eaton, Driffin, Bauermeister, Smith, & Conway‐Washington, ), who represent a historically underserved population. In addition, research regarding low access, uptake, and adherence to PrEP has shown breakdowns in healthcare systems implementing PrEP, a lack of medical providers' knowledge or willingness to prescribe PrEP (Krakower, Ware, Mitty, Maloney, & Mayer, ; Petroll et al., ), and unfavorable community attitudes about PrEP (Krakower et al., ; Liu et al., ).…”